Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Prime Medicine is a biotechnology company that utilizes Prime Editing to modify genetic sequences to treat a wide range of diseases.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
Flexible tools for single cell analysis
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Notch develops immune cell therapy developing a next-generation pipeline that is compatible and focuses on initial cancer cells.
Genomic Life offers genomic products.
A2 Biotherapeutics develops T cell therapies targeting solid tumors precisely.
Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.
Orbital Therapeutics is a biotechnology company that develops RNA-based medicines to treat disease in humans.
Deepcell is a life science company specializing in AI-powered single-cell classification and isolation for basic and translational research.
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.
Reinventing drug development from the ground up to make safe, effective oligonucleotide-based medicines possible on demand.
Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.
Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.
Flare Therapeutics is a biotech startup that creates precision therapies for cancer and other disorders by targeting transcription factors.
InnoSIGN is a manufacturer of precision medicine for diagnostics and drug development applications.
Basilard BioTech features a technology platform that transforms the rapidly growing cell-based therapies market.
Arzeda is a protein design company that creates and manufactures proteins and enzymes for pharmaceuticals and industrial chemicals.
TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.
IVexSol is a lentiviral vector production platform that supplies a consistent source of vectors for successful gene therapy programs.
Foghorn Therapeutics is developing therapies based on a system that directs which genes our cells express,
Contineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
Octave is a precision care company that provides diagnostic tools and care solutions for neurodegenerative diseases.
Casdin Capital has invested in 95 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Casdin Capital's top investment sectors include Biotechnology, Health Care, Life Science, Genetics, Therapeutics. The firm invests across 24 different industry categories.
Among tracked funding rounds, Revolution Medicines received $1.5B in a Post-IPO Equity round. Casdin Capital's total known invested capital is $9.0B.
Casdin Capital's average investment size is $114.8M across its portfolio of 95 companies.
Recent Casdin Capital portfolio additions include Prime Medicine, Auron Therapeutics, Scribe Biosciences, 4D Molecular Therapeutics, Notch Therapeutics. These companies were founded in 2020 or later.